Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures
Status:
Completed
Trial end date:
2017-01-24
Target enrollment:
Participant gender:
Summary
Study to evaluate the efficacy of Lacosamide (LCM) administered in addition to 1 to ≤3 other
Anti-Epileptic Drugs in subjects with epilepsy ≥4 years to <17 years of age who currently
have uncontrolled partial onset seizures.